Podcasts > Archived Podcasts > Industry Focus
This show is no longer producing new episodes. Check out our other shows.
Industry Focus
Healthcare: Frustrating Flops, Plus Welcome to the Wrinkle Wars
Feb 13, 2019 (25:02)
What Gilead Sciences and Sangamo Therapeutics disappointing data means to investors and why Allergan may face a formidable foe in up-and-comer Evolus. Stocks: GILD, SGMO, AGN, EOLS
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.